3 H]thymidine uptake and cell proliferation was completely abolished if activation of cPLA 2 was prevented. The response of macrophages to ␣ 2 M* requires transcription factors nuclear factor B, and cAMP-responsive element-binding protein as well as expression of the proto-oncogenes c-fos and c-myc. These studies indicate that the activation of cPLA 2 plays a crucial role in ␣ 2 M*-induced mitogenesis and cell proliferation.
1 undergoes a major conformational change when it binds proteinases (1, 2) . Each ␣ 2 M subunit also contains an internal thiol ester, which can be directly attacked by small nucleophiles resulting in a similar conformational change (1) . In either event, receptor recognition sites are exposed in each of the subunits (1) . These receptor-recognized forms of ␣ 2 M, termed ␣ 2 M*, bind to the low density lipoprotein receptorrelated protein (LRP) present on a variety of cells including macrophages (1) (2) (3) . In 1993, we demonstrated that the binding of ␣ 2 M* to macrophages activated signaling cascades characterized by an inositol 1,4,5-trisphosphate (IP 3 )-dependent increase in [Ca 2ϩ ] i (4) . Subsequent studies demonstrated that the binding to macrophages activates a pertussis toxin-insensitive phospholipase C, which hydrolyzes membrane phosphoinositides generating both IP 3 and diacylglycerol (5, 6) . These studies also demonstrated that ␣ 2 M*-mediated signal transduction was not blocked by addition of receptor-associated protein (RAP). Because RAP blocks the binding of all known ligands to LRP, this observation suggested the presence of a second ␣ 2 M* receptor on macrophages, which was termed the ␣ 2 M* signaling receptor (␣ 2 MSR) (1, 5, 6) . In support of the identification of a distinct ␣ 2 M* receptor were several other observations. Two classes of binding sites were identified on macrophages, one of high affinity and low capacity (K d ϳ 50 pM and ϳ1600 sites/cell) and the other LRP, which demonstrated lower affinity and higher binding capacity (K d ϳ2-5 nM and ϳ70,000 sites/cell) (7) (8) (9) (10) . Binding of other ligands to LRP, moreover, initiated signaling cascades that activated a pertussis toxin-sensitive G protein and were blocked by addition of RAP (4 -12) . More recent observations, however, suggest that ␣ 2 M*-mediated signal transduction requires the presence of LRP on cells (13) . Thus, Backsai et al. (13) have shown that ␣ 2 M* binding to LRP on neuronal cells mediates signaling via N-methyl-D-aspartate receptors. These authors suggest that an adapter protein causes LRP to associate with this receptor, allowing ␣ 2 M* to activate signal transduction. Furthermore, Herz and colleagues (14, 15) have identified a large number of adapter proteins that can associate with LRP, and Barnes et al. (16) have demonstrated that Tyr-phosphorylated LRP associates with the adapter protein SHC in SRC-transformed cells.
Based on our observations with respect to activation of the p21 ras -dependent MAPK and PI 3-kinase signaling cascades and subsequent cell proliferation, we have proposed that ␣ 2 M* functions like a growth factor (9, (17) (18) (19) (20) . Known growth factors activate cytosolic phospholipase A 2 (cPLA 2 ) and the products of cPLA 2 hydrolysis are involved in the growth-promoting effects of these factors (21) (22) (23) (24) (25) (26) . We, therefore, have studied the effect on cPLA 2 activation of ligating ␣ 2 M* receptors on peritoneal macrophages. Specifically, we studied activation of PKC, MEK 1/2, ERK 1/2, p38 MAPK, JNK, and cPLA 2 ; translocation to nuclei and membranes; modulation of cell division by inhibitors of MAPKs and cPLA 2 ; activation of transcription factors NFB and CREB; and expression of c-fos and c-myc proto-oncogenes.
EXPERIMENTAL PROCEDURES
Materials-The sources of thioglycollate, cell culture materials, [ 3 H]thymidine, BAPTA/AM, genistein, staurosporine, chelerythrine, manumycin A, SB 203580, PD98059, U0126, AACOCF 3 , wortmannin, and EGF have previously been described (6, 10) . 1-(6-C17␤-3-Methoxyestra-1,3,5(10)-trien-17-yl) aminohexyl)-1H-pyrrole-2,5-dione (U73122) was purchased from Biomol (Plymouth Meeting, PA). Bromoenol lactone (BEL) and pertussis toxin were procured from Sigma. Endotoxin-free ␣ 2 M*, binding site mutants of ␣ 2 M*, and RAP were prepared as described previously (9, 10) . Antibodies against phosphorylated MEK 1/2, ERK 1/2, p38 MAPK, and JNK were purchased from New England Biolabs (Mississauga, Ontario, Canada). Antibodies against c-Fos, c-Myc, CREB, and NFB proteins were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). [ 3 H]Methylcholine with specific activity of 60 -90 Ci/mol was purchased from ARC (St. Louis, MO). Silica gel G plates were from Analytical Technology (Newark, DE). Lipid standards were purchased from Avanti Polar Lipids (Alabaster, AL). Xestospongin C was purchased from Calbiochem (San Diego, CA), GDP␤S and GTP␥S were obtained from Roche Molecular Biochemicals, and AlF 3 was from Sigma. Culture media were from Invitrogen. All other chemicals and solvents used were of the highest available grade.
Cell Culture-Thioglycollate-elicited peritoneal macrophages were obtained from pathogen-free 6-week-old C57BL/6 mice (Charles River Laboratories, Raleigh, NC) in Hanks' balanced salt solution containing 10 mM HEPES, pH 7.4, and 3.5 mM NaHCO 3 (HHBSS). The cells were washed with HHBSS and suspended in RPMI 1640 medium containing 2 mM glutamine, 12.5 units/ml penicillin, 6.25 g/ml streptomycin, and 5% fetal bovine serum and plated at a cell density of 3.5-4 ϫ 10 6 cells/4.5 cm 2 . The monolayers were incubated for 2 h at 37°C in a humidified CO 2 (5%) incubator. The monolayers were washed with HHBSS three times to remove nonadherent cells, and monolayers were incubated overnight at 37°C in RPMI 1640 medium containing the additions listed above except that 0.2% fatty acid-free BSA replaced the serum.
Measurement of cPLA 2 Activity-Macrophage monolayers adhered for 2 h in RPMI 1640 medium were radiolabeled with [ 3 H]methylcholine (2 Ci/ml) for 16 -18 h at 37°C in a humidified CO 2 (5%) incubator. The monolayers were washed three times with cold HHBSS, a volume of the buffer (300 l) added, and monolayers (3 ϫ 10 6 cells/well) incubated for 5 min at 37°C prior to stimulation with 100 pM ␣ 2 M, ␣ 2 M*, the 17-kDa receptor-binding fragment of ␣ 2 M* (RBF), or its mutant K1370A for various periods of time. Studies were also performed with EGF (10 ng/ml) as a control. The reaction was stopped by aspirating the medium and adding a volume of chilled methanol. The cells were scraped into screw cap glass tubes and lipids extracted according to Bligh and Dyer (27) . The organic layer was evaporated to dryness under N 2 at 37°C, dissolved in a volume of CHCl 3 :CH 3 OH (2:1, v/v), and processed for lipids fractionation. The choline-labeled lipids were fractionated on heat activated silica gel G plates in solvent system CHCl 3 :CH 3 (29) , were examined, [ 3 H]methylcholine-labeled macrophages (3 ϫ 10 6 cells/well) were incubated with these agents for the specified time before adding ␣ 2 M*. Other details were as described above.
Heterotrimeric G Proteins and cPLA 2 Activity-Macrophages (3 ϫ 10 6 cells) were labeled with [ 3 H]methylcholine as described above. The labeled monolayers were permeabilized with saponin as described previously and pretreated with GTP␥S (20 M) for 5 min at 37°C prior to stimulation with ␣ 2 M* (5). This concentration was chosen after studies to determine the maximal effect of GTP␥S on cPLA 2 activation by ␣ 2 M* (data not shown). Experimental details for lipid isolation, fractionation, and counting were as described above. To further examine the involvement of heterotrimeric G proteins in ␣ 2 M*-induced activation of cPLA 2 activity, we employed GDP␤S and AlF 3 . GDP␤S, a nonhydrolyzable analog of GDP, competitively inhibits G protein activation by GTP and GTP analogs (30) . AlF 3 , on the other hand, mimics the terminal phosphate of GTP, such that the structures of the G␣-GDP-AlF n complexes resemble that of the GTP-bound form of the protein (31 3 H]methylcholine as described above. Pertussis toxin (1 g/ml) was added to the monolayers during the last 12 h of incubation (5) . Pertussis toxin-treated macrophages were washed with cold HHBSS, a volume of the buffer added, and the cells preincubated for 5 min at 37°C prior to stimulation with ␣ 2 M*. Other details of lipid isolation, lipid fractionation, and counting were as described above.
Modulation of Phosphatidylinositol-dependent Phospholipase C (PI-PLC) Activity and cPLA 2 Activation-To understand the role of G protein-coupled PI-PLC activity on cPLA 2 activation in ␣ 2 M*-stimulated macrophages, we employed U73122, which is an relatively specific inhibitor of G protein-mediated PI-PLC activation and PI-PLC-linked events (33) . To [ 3 H]methylcholine-labeled and washed macrophages in RPMI 1640 medium, U73122 (2 M) was added, cells incubated for 10 min as above and then stimulated with ␣ 2 M* (100 pM/20 min). The reaction was terminated by aspirating the medium and adding a volume of methanol. Other details for quantifying radioactivity in the [ 3 H]lysoPC fraction were as described above. We also examined the role of IP 3 generated upon hydrolysis of phosphatidylinositol 4,5-bisphosphate by G protein-coupled PI-PLC in cPLA 2 activation, by inhibiting its binding to IP 3 receptors (IP 3 R) and hence release of endoplasmic reticulum sequestered Ca 2ϩ , with xestospongin C, an antagonist of IP 3 R (34). To [ 3 H]methylcholine-labeled macrophages in RPMI 1640 medium was added xestospongin C (5 M), and the cells were incubated for 10 min as above prior to addition of ␣ 2 M* (100 pM/20 min). The reaction was terminated by aspirating the medium and adding a volume of methanol added. Other details of determining radioactivity in [ 3 H]-lysoPC fraction were as described above.
Measurements of [ 3 H]Thymidine
Uptake by Macrophages-Murine peritoneal macrophages harvested as above were allowed to adhere for 2 h in RPMI 1640 medium containing 0.2% fatty acid-free BSA, penicillin, streptomycin, and glutamine at 37°C in a humidified CO 2 (5%) incubator. The monolayers were washed twice with HHBSS and a volume of above RPMI medium added, followed by the addition of [ 3 H]thymidine (2 Ci/ml) (9, 17) . To the respective wells ␣ 2 M* (100 pM) or PDGF (10 ng/ml) were added. In experiments where the effect of AACOCF 3 (20 M/15 min), PD98059 (50 M/90 min), or SB 203580 (15 M/15 min) were studied, these were added to their respective wells and cells incubated for the specified time before adding ␣ 2 M* or PDGF. The cells were incubated overnight in a humidified CO 2 (5%) incubator. The incubations were terminated by aspirating the medium and washing macrophages twice first with 5% trichloroacetic acid (15 min/4°C), and then three times with HHBSS. The monolayers were lysed with 1 N NaOH and an aliquot used for liquid scintillation counting and protein estimation (35) .
Determination of Macrophage Cell Number-Because increased DNA synthesis is generally associated with an increase in total cellularity, the number of macrophages before and after overnight exposure to varying concentrations of ␣ 2 M* was determined. Peritoneal macrophages were harvested and allowed to adhere in six-well plates in RPMI 1640 medium containing 5% fetal bovine serum for 2 h as described above. The adhered cells were carefully scraped, centrifuged at 1200 rpm for 5 min, and suspended in 15 ml of RPMI 1640 medium containing 0.2% fatty acid-free BSA, and 0.5-ml aliquots (2 ϫ 10 5 cells) were pipetted into 15-ml siliconized polypropylene tubes. To the respective tubes, a specified concentration of ␣ 2 M* was added, the contents mixed gently, and the tubes incubated overnight as above. After overnight incubation, 10 l of trypan blue solution was added to each tube, the tubes gently shaken during incubation for 2 min, and a 10-l aliquot employed for counting the number of cells in a hemocytometer. In experiments where the modulation in cell numbers of ␣ 2 M*-exposed macrophages (2 ϫ 10 5 cells/tube) was studied, SB203580, a specific inhibitor of p38 MAPK (15 M/30 min) (36); PD98059, a specific inhibitor of MEK 1/2 (50 M/90 min) (37); U0126, a specific inhibitor of MEK 1/2 (1 M/10 min) (38) ; AACOCF 3 (20 M/15 min) (39) ; and wortmannin, a specific inhibitor of PI 3-kinase (30 nM/30 min) (40) were added to the respective tubes, and tubes incubated for the specified time before adding ␣ 2 M* (100 pM). The tubes were incubated and cell numbers counted as described above.
Western Blotting of Phosphorylated MEK 1/2, ERK 1/2, p38 MAPK, and JNK in Macrophages Stimulated with ␣ 2 M*-Freshly harvested peritoneal macrophages in RPMI 1640 medium containing penicillin, streptomycin, glutamine, and 0.2% fatty acid-free BSA were allowed to adhere in six-well plates (3 ϫ 10 6 cells/well) for 2 h as above. The monolayers were washed twice with HHBSS, a volume of above RPMI 1640 medium added, and plates incubated overnight as above. The monolayers were washed twice, a volume of RPMI medium containing 0.2% fatty acid-free BSA added, and the cells pretreated with specific inhibitors/modulators of MAPKs for the specified time period before exposing to ␣ 2 M* (100 pM/20 min) or buffer. The incubations were terminated by aspirating the medium. The lysis of cells, their electrophoresis, and Western immunoblotting were performed according to the manufacturer's instruction. In each case, an equal amount of protein was employed for electrophoresis. The detection of phosphorylated MAPKs by enhanced chemifluorescence and quantification of their distribution was performed by phosphorimaging (Storm ® ).
Western Blotting of c-Fos, c-Myc, CREB, and NFB Proteins in
Macrophages Exposed to ␣ 2 M*-Freshly harvested peritoneal macrophages in RPMI 1640 medium containing penicillin, streptomycin, glutamine, and 0.2% BSA were allowed to adhere in six-well plates (3 ϫ 10 6 cells/well) for 2 h as above. The monolayers were washed twice with HHBSSS, a volume of above RPMI 1640 medium added, and plates incubated overnight as above. The monolayers were washed, a volume of above RPMI medium added, and the cells incubated with specific inhibitors/modulators of MAPKs or a Ca 2ϩ chelator, for the specified time period before exposing to ␣ 2 M* (100 pM/20 min) or buffer. The incubations were terminated by aspirating the medium. The lysis of cells, their electrophoresis, and Western immunoblotting were performed according to the manufacturer's instruction. In each case, an equal amount of protein was employed for electrophoresis. The detection of immunoblots was performed by enhanced chemifluorescence, and quantitation of their distribution was done by phosphorimaging (Storm ® ). 3 H]methylcholine (2 Ci/ml) for 16 -18 h at 37°C in a humidified CO 2 (5%) incubator. The radiolabeled monolayers were washed three times with cold HHBSS, a volume of the buffer added, and monolayers incubated for 5 min at 37°C prior to stimulation with ␣ 2 M* (100 pM) for various periods of time. The reaction was stopped by aspirating the medium, and a volume of "buffer A" containing 20 mM Tris-HCl, pH 7.4, 10 mM KCl, 2 mM MgCl 2 , 1 mM phenylmethylsulfonyl fluoride, 20 g/ml leupeptin, 0.3 mM CaCl 2 , 1 mM NaF, and 1 mM sodium orthovanadate was added. Cells were allowed to swell for 10 min on ice, followed by the addition of three volumes of "buffer B" containing 50 mM Tris-HCl, pH 7.4, 25 mM KCl, 5 mM MgCl 2 , 0.25 M sucrose, 1 mM phenylmethylsulfonyl fluoride, 20 g/ml leupeptin, 0.2 mM EGTA, 0.2 mM CaCl 2 , 1 mM NaF, 1 mM sodium orthovanadate, and 100 mM benzamidine. The cells were scraped into glass tubes containing sodium orthovanadate and 100 mM benzamidine and homogenized in a Potter-Elvehjem homogenizer by 15 up-and-down strokes at 4°C. The homogenates were centrifuged for 10 min at 800 ϫ g, 40°C. Supernatant was carefully removed, nuclear pellets washed with cold buffer B twice by centrifuging, and the pellets suspended in a volume of buffer B. The supernatant was layered on a 30 -70% sucrose gradient and centrifuged at 200,000 ϫ g for 60 min at 40°C. The membrane-enriched fraction at the sucrose interface was collected and pelleted at 200,000 ϫ g, and the pellet, containing both endoplasmic reticulum and plasma membranes, was suspended in a volume of buffer B. The supernatant remaining after membrane isolation is considered as "cytosol." Nuclei, membrane fractions, and cytosol were prepared under identical conditions in all experiments. The purity of cell fractions was evaluated by electron microscopy as described previously (41) (42) (43) . Equal amounts of cytosol, membrane, or nuclear protein was processed in each experiment for lipid isolation. The details of lipid isolation, lysoPC fractionation by thin layer chromatography, and counting of radioactivity in the lysoPC fraction were as described above. In experiments where the effects of inhibition of MEK 1/2, p38 MAPK, or cPLA 2 were examined on ␣ 2 M*-induced translocation of cPLA 2 to cellular membranes, the [
3 H]methylcholine-labeled macrophages were incubated with inhibitors of these enzymes for the specified time period before adding ␣ 2 M* as described above. The reactions were terminated by aspirating the media. Other details of preparing subcellular frac- tions, lipid isolation, lysoPC fractionation, and counting of radioactivity were as described above. 2 ActivitycPLA 2 catalyzes the hydrolysis of phosphatidylcholine generating arachidonic acid and lysoPC as its products (21) (22) (23) (24) (25) (26) . Thus, the quantification of either product has been employed to study cPLA 2 activation (21-26). In our studies, macrophage cPLA 2 activity was quantified by measuring the levels of 3 H]methylcholinelabeled macrophages with 100 pM ␣ 2 M*, or RBF, increased cPLA 2 activity by ϳ2-fold compared with buffer or native nonactivated ␣ 2 M-treated macrophages (Fig. 1A) . Under our experimental conditions, the maximal increase in [ 3 H]lysoPC in ␣ 2 M*-stimulated macrophages occurred at about 10 min after stimulation and it plateaued thereafter (Fig. 1A) . RBF binding site mutant K1370A induces signal transduction when it binds to macrophage ␣ 2 M* receptors, which belong to the class defined as ␣ 2 MSR (7, 8) . Addition of this mutant RBF also increased [ 3 H]lysoPC generation comparably to ␣ 2 M* or EGF (Fig. 1B) . ␣ 2 M* binds to growth factors and cytokines, but RBF and K1370A lack the growth factor binding domain (44) . Thus, these studies demonstrate that the observed effects are related directly to ␣ 2 M* cellular binding. cPLA 2 activity increased nearly linearly up to a concentration of 50 -100 pM ␣ 2 M* and it plateaued at higher concentrations (Fig. 1C) . The kinetics of ␣ 2 M*-induced increase in cPLA 2 activity parallels those observed in ␣ 2 M*-induced increase in [Ca 2ϩ ] i , IP 3 (17) , phospholipase D activation, PI 3-kinase activation (10), and p21 ras activation reported previously (20) .
RESULTS

Binding of ␣ 2 M* to Macrophages Induces cPLA
␣ 2 M*-induced Activation of cPLA 2 Is RAP-and BEL-insensitive-RAP, the 39-kDa receptor-associated protein does not block ␣ 2 M*-induced signal transduction, but does block signaling by all other LRP ligands so far studied (5, 17) . The results presented in Fig. 2A show that the ligation of macrophage receptors with either ␣ 2 M* or the RBF binding site mutant K1370A, activates cPLA 2 activity in the presence of RAP, as expected from this fact. Chelation of [Ca 2ϩ ] i with BAPTA/AM, completely abolished ␣ 2 M*-stimulated cPLA 2 activity (Fig. 2B) . We further evaluated the Ca 2ϩ sensitivity of ␣ 2 M*-induced increase in cPLA 2 activity by using BEL, a very potent inhibitor of Ca 2ϩ independent PLA 2 ( Fig. 2C) . Preincubation of labeled cells with BEL had no effect on cPLA 2 activity stimulated by ␣ 2 M* or K1370A (Fig. 2C) , which demonstrates that ␣ 2 M* induces the activity of a Ca 2ϩ -dependent cytosolic PLA 2 . To rule out the contribution of endotoxin in ␣ 2 M* or K1370A-induced activation of cPLA 2 activity, the labeled cells were treated with boiled ␣ 2 M* and cPLA 2 activation measured (Fig.  2C) . In addition all preparations were endotoxin-free as determined by assay (data not shown). The results indicate that endotoxins do not contribute to agonist-induced stimulation of cPLA 2 activity. (20 M) to saponin-permeabilized cells caused a nearly 2-fold increase in cPLA 2 activity compared with that observed with ␣ 2 M* alone (Fig. 3A) . Preincubation of cells with GDP␤S prior to addition of GTP␥S and ␣ 2 M* nearly abolished ␣ 2 M*-stimulated cPLA 2 activity (Fig. 3B) . Further, treatment of cells with AlF 3 , as expected, potentiated the ␣ 2 M*-induced increase in cPLA 2 activity (Fig. 3C) . These results strongly support the involvement of a heterotrimeric G protein in the activation of cPLA 2 by ␣ 2 M*. We propose that cPLA 2 activation in ␣ 2 M*-stimulated cells requires a heterotrimeric G protein coupled to PI-PLC. If this hypothesis is correct, inhibition of PI-PLC activation and blocking the binding of second messenger generated consequent to PI-PLC activation to the effector molecules should inhibit agonist-induced cPLA 2 activation. The results shown in Fig. 3C demonstrate that, indeed, either the inhibition of PI-PLC with U73122 or the inhibition of binding of newly generated IP 3 to IP 3 R by xestospongin C inhibited c-PLA 2 activation in ␣ 2 M*-stimulated cells. We next treated pertussis toxin preincubated cells with ␣ 2 M* and quantified the release of [ 3 H]lysoPC (Fig. 3D ). The results demonstrate that the G protein involved in ␣ 2 M*-mediated stimulation of cPLA 2 activity is pertussis toxininsensitive. Activation of cPLA 2 by receptor-coupled G proteins may be mediated by direct interaction of these G proteins with cPLA 2 (21) (22) (23) (24) (25) (26) . In addition, G protein-dependent activation of PLC increases DAG and IP 3 , the latter of which raises [Ca 2ϩ ] i . Activation of PKC, activation of MAPKs, and subsequent phosphorylation and activation of cPLA 2 then occur (21, 26) .
Phosphorylation of MEK 1/2, ERK 1/2, PKC, p38 MAPK, and JNK in ␣ 2 M* Induces Activation of cPLA 2 -We next examined the involvement of MEK 1/2, ERK 1/2, p38 MAPK, and JNK in cPLA 2 activation in two ways, namely by quantifying the levels of phosphorylated (activated) forms of these MAPKs by Western blotting and by inhibiting MEK 1/2 or p38 MAPK with their specific inhibitors before stimulating macrophages with ␣ 2 M* and quantifying [ 3 H]lysoPC. Inhibition of p38 MAPK with SB203580, and of MEK 1/2 with PD98059 or U0126, nearly abolished ␣ 2 M*-induced increase in cPLA 2 activity and release of [ 3 H]lysoPC, an effect comparable with treating cells with AACOCF 3 , a cPLA 2 inhibitor (Fig. 4A) . Treatment of labeled macrophages with genistein, a tyrosine kinase inhibitor, had no effect on ␣ 2 M*-induced increase in cPLA 2 activity (Fig. 4B) . The binding of ␣ 2 M* to ␣ 2 MSR activates the hydrolysis of membrane phosphatidylinositol bisphosphate via both PLC␤ and PLC␥ (4, 12). We have shown that the ligation of ␣ 2 MSR with ␣ 2 M* stimulates PLC␥ activity, which is sensitive to genistein (12) . Because genistein treatment did not affect ␣ 2 M*-induced cPLA 2 activity, the studies suggest that PLC␤ is involved in the activation of cPLA 2 . Inhibition of PI 3-kinase with wortmannin, however, did not affect cPLA 2 activation. These results are consistent with published studies demonstrating that both ERK 1/2 and p38 MAPK are involved in the phosphorylation of cPLA 2 at Ser-505, which is essential for its activation (21) (22) (23) (24) (25) (26) .
Stimulation of murine peritoneal macrophages with ␣ 2 M* caused ϳ2-fold increase in the expression of phosphorylated MEK 1/2 protein (Fig. 5A) , phosphorylated ERK 1/2 protein (Fig. 5B) , phosphorylated p38 MAPK protein (Fig. 6A) , and phosphorylated JNK protein (Fig. 6B) . ␣ 2 M*-induced increased phosphorylation of MEK 1/2 was inhibited by chelation of Ca 2ϩ with BAPTA/AM or inhibition of PKC with chelerythrine (Fig.  5A) . ␣ 2 M*-induced increase in ERK 1/2 phosphorylation was drastically inhibited by PD98059, U0126, chelation of [Ca 2ϩ ] i with BAPTA/AM, or inhibition of PKC with chelerythrine (Fig.  5B) . Inhibition of PKC as well as chelation of [Ca 2ϩ ] i abrogated ␣ 2 M*-induced increase in phosphorylated p38 MAPK protein (Fig. 6A) . The increase in JNK protein phosphorylation in ␣ 2 M*-stimulated macrophages was reduced by BAPTA/AM or chelerythrine (Fig. 6B) .
In many cells, PKC regulates MAPK pathways either alone or in combination with other mechanisms (21) (22) (23) (24) (25) (26) (45) (46) (47) . To further examine the involvement of PKC, we quantified the activity of cPLA 2 in macrophages in which PKC activity was downregulated with PMA, or inhibited by chelerythrine or staurosporine, respectively (Fig. 4B) . Inhibition of PKC with its inhibitors or its down-regulation nearly abolished ␣ 2 M*-induced increase in cPLA 2 activity, as determined by quantifying of [ 4B ). In contrast, up-regulation of PKC significantly increased cPLA 2 activity in ␣ 2 M*-treated cells (Fig. 4B) .
␣ 2 M*-induced Translocation of cPLA 2 to Nuclei and Membranes-cPLA 2 activity as determined was present both in nuclei and the membrane fractions (Fig. 7) . Immediately after ␣ 2 M* stimulation, cPLA 2 activity increased in the nuclear fraction reaching a maximal level at 15 min and plateauing at longer periods of incubation (Fig. 7A ). In contrast, the peak cPLA 2 activity in the membrane fraction occurred between 2 and 5 min after ␣ 2 M* stimulation and then declining to a steady state level. Very little cPLA 2 activity was present in the cytosol after ␣ 2 M* stimulation. The results demonstrate that, in ␣ 2 M*-stimulated macrophages, the nuclear membranes are the main target for cPLA 2 translocation, although some activity is associated with other membranes. Treatment of macrophages with PD98059 or SB203580 before stimulating them with ␣ 2 M* inhibited cPLA 2 activity in nuclei (Fig. 7B) . No inhibition in ␣ 2 M*-induced increase in [Ca 2ϩ ] i was observed in these studies; hence, the reduced nuclear cPLA 2 (Fig. 8) . Like PDGF, ␣ 2 M* and K1370A increased [ 3 H]thymidine uptake by macrophages by ϳ2-fold (Fig. 8A) . The agonist-induced increase in [ 3 H]thymidine uptake was abolished by AACOCF 3 , a specific inhibitor of cPLA 2 , by PD98059, or by SB 203580 (Fig. 8B) . These results demonstrate that cPLA 2 activity and MAPK activation is intimately involved in ␣ 2 M*-induced increases in [ 3 H]thymidine uptake. independent of new nucleic acid synthesis. Because new DNA synthesis is normally associated with an increase in total cellularity, we determined the macrophage cell number before and after overnight incubation with varying concentrations of ␣ 2 M* (Fig. 8B) . The maximal increase in macrophage numbers occurred at 50 -100 pM ␣ 2 M*, and the cell numbers plateaued at higher concentrations of ␣ 2 M* (Fig. 8B) . The kinetics of ␣ 2 M*-induced increase in cell number is similar to that observed for ␣ 2 M*-induced increase in protein and DNA synthesis (17) . Inhibition of cPLA 2 by AACOCF 3 or inhibition of MAPKdependent phosphorylation of cPLA 2 abolished ␣ 2 M*-induced increase in macrophage cell number (Fig. 8C) . (Fig. 9A) . Ligation of ␣ 2 MSR on macrophages elevates cyclic AMP (cAMP) levels by ϳ50% (4). cAMP, an important intracellular second messenger, mediates the transcriptional induction of many genes through PKA-dependent phosphorylation of transcription factor CREB (48 -50) . This reaction modulates its nuclear transport, and DNA binding affinity, thus enhancing its transactivation potential (49, 50) . Stimulation of macrophages with ␣ 2 M* (100 pM/20 min) increased the expression of CREB by ϳ2-fold (Fig.  9B) , suggesting thereby the involvement of CREB in ␣ 2 M*-induced mitogenic responses in macrophages. Inhibition of MEK 1/2 or p38 MAPK in ␣ 2 M*-stimulated macrophages reduced ␣ 2 M-induced increased expression of NFB protein by ϳ25-30% (Fig. 9A ) and profoundly reduced ␣ 2 M*-induced increase in CREB protein expression (Fig. 9B) . These results suggest that both translational and transcriptional regulation of ␣ 2 M*-induced cellular responses are mediated by cPLA 2 activation.
c-Fos and c-Myc Protein Levels in Macrophages-To understand the involvement of two early genes, namely c-fos and c-myc, in ␣ 2 M*-induced mitogenesis and cell proliferation, we next quantified the c-Fos and c-Myc proteins in ␣ 2 M*-stimulated macrophages by Western blotting and phosphorimaging (Fig. 10, A and B) . ] i . Multifactorial regulation of cPLA 2 activity has been reported, which is cell-and agonist-specific. These factors include transcriptional regulation involving heterotrimeric G proteins, increase in [Ca 2ϩ ] i , activation of PKC, cPLA 2 translocation and membrane localization, and phosphorylation by MAPKs (21) (22) (23) (24) (25) (26) . Involvement of G proteins in cPLA 2 activation may occur directly through interaction of heterotrimeric G proteins with the enzymes or indirectly by activation of signaling cascades subsequent to receptor ligation (21) (22) (23) (24) (25) (26) . Phosphorylation at Ser-505 of cPLA 2 is essential for agonist-induced arachidonic acid release in many, but not all, types of cells (21) (22) (23) (24) (25) (26) 
